These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sepsis Care Pathway 2019. Labib A Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206 [No Abstract] [Full Text] [Related]
3. Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway. Nakamori Y; Park EJ; Shimaoka M Front Immunol; 2020; 11():624279. PubMed ID: 33679715 [TBL] [Abstract][Full Text] [Related]
4. Advances in the Study of Immunosuppressive Mechanisms in Sepsis. Fu X; Liu Z; Wang Y J Inflamm Res; 2023; 16():3967-3981. PubMed ID: 37706064 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression. Patil NK; Bohannon JK; Sherwood ER Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649 [TBL] [Abstract][Full Text] [Related]
6. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se). Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416 [TBL] [Abstract][Full Text] [Related]
7. Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy. De Kock I; Van Daele C; Poelaert J Acta Clin Belg; 2010; 65(5):323-9. PubMed ID: 21128559 [TBL] [Abstract][Full Text] [Related]
8. The immune system's role in sepsis progression, resolution, and long-term outcome. Delano MJ; Ward PA Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333 [TBL] [Abstract][Full Text] [Related]
9. Targeting the host response in sepsis: current approaches and future evidence. Bode C; Weis S; Sauer A; Wendel-Garcia P; David S Crit Care; 2023 Dec; 27(1):478. PubMed ID: 38057824 [TBL] [Abstract][Full Text] [Related]
10. EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial. David S; Bode C; Stahl K; Trials; 2023 Apr; 24(1):277. PubMed ID: 37061693 [TBL] [Abstract][Full Text] [Related]
11. Hemoadsorption by CytoSorb in septic patients: a case series. Kogelmann K; Jarczak D; Scheller M; Drüner M Crit Care; 2017 Mar; 21(1):74. PubMed ID: 28343448 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory therapies in sepsis. Kox WJ; Volk T; Kox SN; Volk HD Intensive Care Med; 2000; 26 Suppl 1():S124-8. PubMed ID: 10786969 [TBL] [Abstract][Full Text] [Related]
13. New Strategies for Treatment of Sepsis. Mirijello A; Tosoni A; On Behalf Of The Internal Medicine Sepsis Study Group Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33050538 [TBL] [Abstract][Full Text] [Related]
14. Recent advancements of nanomaterial-based therapeutic strategies toward sepsis: bacterial eradication, anti-inflammation, and immunomodulation. Zhao Y; Pu M; Zhang J; Wang Y; Yan X; Yu L; He Z Nanoscale; 2021 Jun; 13(24):10726-10747. PubMed ID: 34165483 [TBL] [Abstract][Full Text] [Related]
15. Fluid Therapy in Dogs and Cats With Sepsis. Montealegre F; Lyons BM Front Vet Sci; 2021; 8():622127. PubMed ID: 33718468 [TBL] [Abstract][Full Text] [Related]
16. [Immunomodulation for sepsis: a change of tack?]. Leentjens J; Kox M; Pickkers P Ned Tijdschr Geneeskd; 2014; 158():A6859. PubMed ID: 24518844 [TBL] [Abstract][Full Text] [Related]
17. Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock. Li D; Li X; Cui W; Shen H; Zhu H; Xia Y Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010593. PubMed ID: 30536956 [TBL] [Abstract][Full Text] [Related]
18. Sepsis-Pathophysiology and Therapeutic Concepts. Jarczak D; Kluge S; Nierhaus A Front Med (Lausanne); 2021; 8():628302. PubMed ID: 34055825 [TBL] [Abstract][Full Text] [Related]
19. Septic shock 3.0 criteria application in severe COVID-19 patients: An unattended sepsis population with high mortality risk. Cidade JP; Coelho LM; Costa V; Morais R; Moniz P; Morais L; Fidalgo P; Tralhão A; Paulino C; Nora D; Valério B; Mendes V; Tapadinhas C; Povoa P World J Crit Care Med; 2022 Jul; 11(4):246-254. PubMed ID: 36051940 [TBL] [Abstract][Full Text] [Related]
20. Towards personalized medicine: a scoping review of immunotherapy in sepsis. Slim MA; van Mourik N; Bakkerus L; Fuller K; Acharya L; Giannidis T; Dionne JC; Oczkowski SJW; Netea MG; Pickkers P; Giamarellos-Bourboulis EJ; Müller MCA; van der Poll T; Wiersinga WJ; ; Vlaar APJ; van Vught LA Crit Care; 2024 May; 28(1):183. PubMed ID: 38807151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]